Archive for April, 2008
New research claims that people with diabetes who take glitazones could be at increased risk of bone fractures. The study found that people taking one of the eight glitazones for 12 to 18 months were at almost double the risk of a fracture, particularly of the hip or wrist, and those taking one of the drugs for more than two years were almost three times the risk.
More: continued here
Medtronic, Inc. (NYSE: MDT) announced it has received approval to market two smaller kit sizes of INFUSEĀ® Bone Graft for use in certain spinal fusion and dental regenerative procedures. The U.S. Food and Drug Administration (FDA) has approved two additional configurations of INFUSE Bone Graft: XX Small (0.7cc) kit and X Small (1.4cc) kit. These new sizes will be available for clinical use this June.
More: continued here
A group of University of Southern California School of Dentistry researchers says it has identified the slimy culprits killing the jawbones of some people taking drugs that treat osteoporosis. Microbial biofilms, a mix of bacteria and sticky extracellular material, are causing jaw tissue infections in patients taking bisphosphonate drugs, said Parish Sedghizadeh, lead researcher and assistant clinical professor at the USC School of Dentistry.
More: continued here
Two genetic variants of important biological proteins have been singledout as increasing the risk of osteoporosis as well as resultingosteoporotic fractures. Additionally, these genetic variants have ahigh enough incidence in the population to potentially be screens forthe disease. This was published in an article released on April 29,2008 in The Lancet. Osteoporosis is a bone disease characterized by an increased risk offracture.
More: continued here
A TOOL with the potential to determine the level of tissue damage in patients with osteo-arthritis, sports injuries and other conditions affecting bone and cartilage is being developed by QUT researchers.This may allow surgeons to make a precise diagnosis and be better equipped for making accurate decisions during treatment.
More: continued here
Chronically irregular heartbeat (atrial fibrillation) affected women who had taken Merck’s bisphosphonate drug Fosamax (alendronate) to combat the bone-thinning disease osteoporosis nearly twice as often as women who had never used it according to new research from the US.
More: continued here
Smith & Nephew’s (NYSE:SNN;LSE:SN) Endoscopy Division announced the launch of the FOOTPRINT PK Suture Anchor, a system used to attach rotator cuff tissue to bone in the shoulder.The anchor is among products featured at the Arthroscopy Association of North America (AANA) Spring Meeting, which began in Washington, D.C.The objective during rotator cuff repair is to return the soft tissue to its original anatomic attachment site.
More: continued here
Osteotech’s Plexur P(TM) Receives FDA Clearance As Bone Void Filler And Bone Graft Extender In Spine
Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic solutions for regenerative medicine, announced that the United States Food and Drug Administration (”FDA”) has cleared its 510(k) submission for the Plexur P(TM) Biocomposite for use in spinal applications as a bone void filler and as a bone graft extender. Previously, Osteotech received FDA clearance for Plexur P(TM) for use in filling bony voids of the pelvis and extremities.
More: continued here
The U.S. Food and Drug Administration (FDA) approved a new once-a-month dose (150 mg) of Actonel(R) (risedronate sodium) tablets for the treatment and prevention of postmenopausal osteoporosis. Actonel is approved to reduce the risk of fractures in postmenopausal women with osteoporosis. The FDA approval of the once-a-month dose is based on a study comparing Actonel 150 mg once monthly to Actonel 5 mg daily.
More: continued here
A computer simulation breakthrough could mean fewer medical complications and better surgical outcomes for patients undergoing hip, knee or spinal implant surgery.Each year surgeons across Europe perform a staggering 900,000 hip, knee and spinal implant operations. Implant surgery is one of the most remarkable advances in medical science. Such operations restore increased mobility and a vastly improved quality of life to millions of Europeans.
More: continued here





